Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-2-21
pubmed:abstractText
bcl-2 expression is associated with the expression of the multidrug resistance molecule (p-gp) and the resistance of leukaemia cells to the induction of apoptosis. The activity of p-gp is the main mechanism of resistance of leukaemia cells to chemotherapy. This study assessed the induction of apoptosis of acute lymphoblastic leukaemia (ALL) and non-Hodgkin's lymphoma (NHL) blastic cells following in vitro treatment with dexamethasone (DXM), vincristine (VCR), and tumour necrosis factor (TNF) in relation to the expression of bcl-2 and p-gp. Common ALL (cALL; n = 24 patients), common ALL with co-expression of myeloid antigens (cALL + My; n = 9), ALL-T (n = 9), and NHL [n = 6 (T type, n = 2; B type, n = 4)] were included. The expression of bcl-2 and p-gp and apoptosis were assayed by flow cytometry. Spontaneous apoptosis was low (< 5%) in cALL and ALL-T and higher (> 8%) in NHL and cALL + My. A high frequency of bcl-2 expression was noted in cALL and cALL + My. A high frequency of p-gp expression was observed in cALL + My, ALL-T, and NHL. There was a reverse association between bcl-2 expression and spontaneous apoptosis. DXM-induced apoptosis was observed in 52.63%, TNF-induced in 42.85%, VCR-induced in 36.36%, and GM-CSF-induced in 33.3% of leukaemia and lymphoma cases. DXM and GM-CSF-driven apoptosis was reversibly associated with bcl-2-expression (bcl-2-dependent mechanism). VCR and TNF-driven apoptosis was not associated with bcl-2 expression, suggesting a different, bcl-2-independent, mechanism(s) of its induction. The in vitro induction of apoptosis was not associated with expression of p-gp.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0017-6559
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
191-207
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11855781-Adolescent, pubmed-meshheading:11855781-Antineoplastic Agents, pubmed-meshheading:11855781-Apoptosis, pubmed-meshheading:11855781-Bone Marrow Cells, pubmed-meshheading:11855781-Child, pubmed-meshheading:11855781-Child, Preschool, pubmed-meshheading:11855781-Dexamethasone, pubmed-meshheading:11855781-Female, pubmed-meshheading:11855781-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:11855781-Humans, pubmed-meshheading:11855781-Lymph Nodes, pubmed-meshheading:11855781-Lymphoma, Non-Hodgkin, pubmed-meshheading:11855781-Male, pubmed-meshheading:11855781-P-Glycoprotein, pubmed-meshheading:11855781-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:11855781-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:11855781-Tumor Necrosis Factor-alpha, pubmed-meshheading:11855781-Vincristine
pubmed:year
2001
pubmed:articleTitle
Induction of apoptosis and bcl-2 expression in acute lymphoblastic leukaemia and non-Hodgkin's lymphoma in children.
pubmed:affiliation
Department of Clinical Immunology, Polish-American Children's Hospital, Jagiellonian University Medical College, Kraków. mipituch@cyf-kr.edu.pl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't